Post hoc mortality analysis on the efficacy trial of diaspirin cross-linked hemoglobin in the treatment of severe traumatic hemorrhagic shock.
Ward
C Gillon
CG
Sloan
Edward P
EP
D001241:Aspirin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006454:Hemoglobins / Q000627:therapeutic use*; D006801:Humans; D012771:Shock, Hemorrhagic / Q000188:drug therapy* / Q000401:mortality*; D012774:Shock, Traumatic / Q000188:drug therapy* / Q000401:mortality*; D016019:Survival Analysis
D006454:Hemoglobins; C083478:diaspirin-cross-linked hemoglobin; D001241:Aspirin